The global liquid biopsy market is projected to reach $12,933 million by 2030 and grow with a significant CAGR of 15.87%
get more detailed : https://bisresearch.com/industry-report/global-liquid-biopsy-market.html
What are the liquid biopsy fundamentals? What are the goals of liquid biopsy? What are the market trends in liquid biopsy? Who's investing in liquid biopsy? What biomarkers are driving liquid biopsy?
Liquid Biopsy Market Global Research Report Forecast to 2021-2026 | MarkNtel ...NarayanSharma67
According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F.
What are the liquid biopsy fundamentals? What are the goals of liquid biopsy? What are the market trends in liquid biopsy? Who's investing in liquid biopsy? What biomarkers are driving liquid biopsy?
Liquid Biopsy Market Global Research Report Forecast to 2021-2026 | MarkNtel ...NarayanSharma67
According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F.
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
Biopsy devices market Research, Industry Trends, Strategies, Growth, Regional...IMARC Group
According to IMARC Group, the global biopsy devices is market to grow at a CAGR of around 5% during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/biopsy-devices-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies.
For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
The global in-vitro diagnostics market size was valued at US$ 60,274.1 million in 2017, and is expected to exhibit a CAGR of 4.6% over the forecast period (2018–2026).
United states breast cancer diagnostic devices market 2010 2020 brochurePharmaion
According to Pharmaion “United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the breast cancer diagnostic devices market in the United States during the period 2010 - 2020.
There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphasis in this TriMark Publications report is on those companies that are actively developing and marketing high-growth diagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors that influence the size and growth of market segments. The study goes on to discuss in detail trends that have developed which have stimulated this market, and also comments in detail patterns of information processing in the high-growth diagnostic testing technologies. Moreover, this exanimation provides an overview of the diagnostic testing market, including the latest information regarding exciting new products and industry trends. It will not only quantify but also qualify the market high-growth segments as an area of research and investment. Forecasts of the market and analyses of products in the worldwide prescriptions market will provide a basis for understanding the significance of past developments and future possibilities within this therapeutic category.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Liquid Biopsy Global Market estimated to be worth $8,730.4 million by 2024Vinay Shiva Prasad
Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for invasive procedures. Raising incidence of cancer and late pregnancies are driving this market.
Our healthcare experts have found COVID-19 Diagnostic Testing industry to be one of the most rapidly evolving and dynamic markets and the global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The somatic genetic testing market is expected to grow at a CAGR of 9.30% during the forecast period from 2020 to 2030. The market is projected to reach $16.79 billion by the end of 2030.
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
Biopsy devices market Research, Industry Trends, Strategies, Growth, Regional...IMARC Group
According to IMARC Group, the global biopsy devices is market to grow at a CAGR of around 5% during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/biopsy-devices-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies.
For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
The global in-vitro diagnostics market size was valued at US$ 60,274.1 million in 2017, and is expected to exhibit a CAGR of 4.6% over the forecast period (2018–2026).
United states breast cancer diagnostic devices market 2010 2020 brochurePharmaion
According to Pharmaion “United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the breast cancer diagnostic devices market in the United States during the period 2010 - 2020.
There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphasis in this TriMark Publications report is on those companies that are actively developing and marketing high-growth diagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors that influence the size and growth of market segments. The study goes on to discuss in detail trends that have developed which have stimulated this market, and also comments in detail patterns of information processing in the high-growth diagnostic testing technologies. Moreover, this exanimation provides an overview of the diagnostic testing market, including the latest information regarding exciting new products and industry trends. It will not only quantify but also qualify the market high-growth segments as an area of research and investment. Forecasts of the market and analyses of products in the worldwide prescriptions market will provide a basis for understanding the significance of past developments and future possibilities within this therapeutic category.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Liquid Biopsy Global Market estimated to be worth $8,730.4 million by 2024Vinay Shiva Prasad
Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for invasive procedures. Raising incidence of cancer and late pregnancies are driving this market.
Our healthcare experts have found COVID-19 Diagnostic Testing industry to be one of the most rapidly evolving and dynamic markets and the global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The somatic genetic testing market is expected to grow at a CAGR of 9.30% during the forecast period from 2020 to 2030. The market is projected to reach $16.79 billion by the end of 2030.
Cell and Gene Therapy Market - Growth Analysis & TrendsBIS Research Inc.
The cell and gene therapy industry analysis by BIS Research projects the market to grow at a significant CAGR of 36.52% during the forecast year 2019-25
The global healthcare service robots market was valued to be $462.3 million in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $2.82 billion by 2025.
DNA Methylation Market _ Industry Analysis & Report BIS Research Inc.
The current DNA methylation market is mainly dominated by several diagnostic majors, such as Exact Sciences Corporation, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc., which offer a wide variety of diagnostics and research-based products for detection of DNA methylation in genomes.
The global female technology market was estimated at $560.5 million in 2018 and is expected to witness a sharp growth of 17.18% during the forecast period 2019-2030.
The digital surgery technologies market was estimated at $252.5 Million in 2019 and is projected to grow at a CAGR of 32.10% during the forecast period from 2020-2030.
The lung cancer genomic testing market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
The Global Point-of-Care Imaging Devices Market was valued to be $8.66 billion in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $19.84 billion by 2030.
Global Neurostimulation Devices Market - Global Industry AnalysisBIS Research Inc.
Neurostimulation devices consider the implantable and non-implantable neurostimulation devices which act on the spinal cord and brain to deliver the electrical stimulation to a targeted area.
The spatial genomics and transcriptomics market was estimated at $269.6 Million in 2020 and is expected to grow at a CAGR of 23.20% during the forecast period from 2020-2030.
The Non-invasive prenatal testing (NIPT) market is projected to reach $10,818.4 Million by 2030 from $2,182.3 Million in 2020, at a CAGR of 15.83% during the forecast period, 2020-2030.
The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The Car T-Cell therapy market is projected to grow at the CAGR of 44.79% during the forecast period from 2020-2030. It is expected to reach $43.04 Billion by the end of 2030.
The global brain imaging modalities market report highlights that the market was valued at $12,334.2 million in 2021 and is expected to reach $20,209.2 million by the end of 2031. The market is expected to grow at a CAGR of 5.06% during the forecast period 2022-2031.
Similar to Liquid Biopsy Market - Analysis & Forecast (20)
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
Cybersecurity in Automotive Connected Vehicles and Growing Security Vulnerabi...BIS Research Inc.
• Agenda:
o To evaluate various security vulnerabilities in connected vehicles.
o To analyze the initiatives taken and regulations implemented to address security vulnerabilities.
o To analyze the various types of cybersecurity solutions being developed or offered for the security of connected vehicles.
o To evaluate the major players in the ecosystem.
Report Preview is available at: https://bisresearch.com/industry-report/global-automotive-cybersecurity-market.html
BIS Research conducted a webinar on Carbon Neutral Data Center PracticesBIS Research Inc.
Agenda:
To evaluate various emerging trends in Data center industry.
To analyze the initiatives taken and regulations implemented to increase sustainable practices.
To analyze the various types of technologies currently deployed.
To evaluate the major players in the ecosystem.
Speaker Profiles:
Name: JD Enright, Sr.
Designation: Chief Operating Officer
Company: TMGcore Inc.
Experienced and dedicated business professional with 29 years working with DOD, Multinational Private and Public sector organizations. Primary focus on developing and executing Strategic Step-Up Growth initiatives in Emerging Markets, and Technologies. Specialized leadership in developing improved business operations to include Financial and Operational efficiencies. Implementation of next generation HPC Platforms, Global Blockchain Development Strategies, Biotechnology, Viral Cell and Gene Therapies and Market Intelligence Assimilation for public applications.
Webinar by BIS Research on Precision Oncology BiomarkersBIS Research Inc.
Precision oncology biomarkers are essential tools for tailoring cancer treatment to individual patients, as they provide insights into tumor biology and guide the selection of targeted therapies.
BIS conducted a deep intelligence webinar on the state-of-the-art technologies and emerging strategies used through the precision oncology biomarkers.
Direct-to-Customer Wellness | A Webinar on the Growing Need for Personalized ...BIS Research Inc.
Direct-to-consumer (DTC) wellness testing industry witnessed a strong emphasis on consumer health and wellness, instigating industry stakeholders to discover new revenue streams.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging trends in the healthcare sector, among several other industry verticals. In the bid to do the same, BIS is conducting a deep intelligence webinar on the increasing focus of DTC wellness programs in the healthcare sector.
Read Related Reports Overview at:
https://bisresearch.com/industry-report/global-direct-to-consumer-genetic-testing-market.html
https://bisresearch.com/industry-report/us-dtc-wellness-testing-market.html
Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Bat...BIS Research Inc.
The efficiency of the battery system in any electric vehicle (EV) determines its cost and vehicle performance. Challenges, such as range anxiety and charging time, have been a hindrance to increasing EV sales.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging technologies in the mobility sector, among several other industry verticals.
In the bid to do the same, BIS is conducting a deep intelligence webinar on the current paradigm shift happening for battery technologies in electric vehicles.
Here are all the details:
Webinar Topic: Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Batteries
Webinar on AI in Medical Diagnosis with Emerging TechnologiesBIS Research Inc.
Artificial Intelligence (AI) is a rapidly growing field that has the potential to revolutionize the way medical diagnosis is performed. AI systems use advanced algorithms to analyze large amounts of data, such as medical images, patient histories, and lab results, to identify patterns and make predictions about patient outcomes.
In medical diagnosis, AI can be used in a variety of ways, including medical imaging, disease diagnosis, personalized treatment planning, and early disease detection. By leveraging the power of AI, healthcare providers can make faster and more accurate diagnoses, resulting in better patient outcomes.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Policy implications related to AI and digital transformation in healthcare.
• Initiatives taken and regulations implemented to address cybersecurity concerns.
• Major factors driving and hindering the growth of AI in medical devices diagnosis.
• Major players in the ecosystem
AI-Enabled Imaging Solutions Market - A Global Market Report by BIS ResearchBIS Research Inc.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. you can get more info to visit this link..
https://bisresearch.com/industry-report/global-ai-enabled-medical-imaging-solutions-market.html
The global demand for achieving the net zero emission target by 2050 has pushed governments all over to adapt and adopt advanced carbon removal technologies to go carbon negative.
It is, indeed, an important topic of discussion, because a carbon free environment is the need of the hour to save our planet. And, therefore, BIS Research is glad to announce its upcoming webinar on this particular subject.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Primary sources of carbon emissions and associated environmental issues
• Carbon dioxide removal – key technology and adoption scenario
• Carbon dioxide removal (CDR): trends and key market developments
• Carbon dioxide removal as a credible solution
• Conclusion and future outlook
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentBIS Research Inc.
Agenda of the Webinar:
Cell and Gene Therapy Biomanufacturing Market: Trends and Key Developments
Awaited Technologies in the Cell and Gene Therapy Development
Regulatory Scenario – GMP/cGMP Guidelines
Biomanufacturing 4.0 - Adoption Scenario
Conclusion and Future Outlook
Sub-Orbital Testing Services Market Future Growth and Business Opportunities ...BIS Research Inc.
Sub-orbital platforms are increasing access to the near space-like environment for end users such as government agencies, research institutions, and commercial players.
The competitive landscape of the sub-orbital testing services market consists of several organic and inorganic strategies followed by the key players to increase their market share.
The space industry is continuously innovating and developing advanced technologies with the objective of enhancing space capabilities. The industry is gearing up to develop vehicles that entail a major feature, i.e., reusability.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
TOC - Global Military Robotic and Autonomous Systems (RAS) Market.pdfBIS Research Inc.
The robotic and autonomous system (RAS) is a multidisciplinary scientific and technological domain for implementing complex systems with cognitive capabilities.
RAS in military is being rigorously introduced and used in combat training. This has boosted the capabilities of armed units and subunits. The advent of artificial intelligence (AI) and its integration with military RAS has the potential to change future warfare.
Growing demand to increase warfighter lethality and remove soldiers from dangerous situations is propelling the global military RAS market.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
UAV Propulsion System Market Analysis, Statistics, Regional, and Forecast to ...BIS Research Inc.
UAV propulsion system manufacturers have also been inclined to counter the environment and other government regulations by developing sustainable propulsion, i.e., steps toward fossil-free aviation fuels and ion propulsion are a few of such significant innovations.
UAVs can be powered by a variety of different types of engines, including piston engines, turbine engines, Wankel engines, and electric and solar-powered engines.
The global UAV propulsion system market has witnessed a high growth rate in the last five to six years owing to its widespread applications across various industries, which were further bolstered by the COVID-19 pandemic.
Publication of BIS Research on UAV Propulsion System market has some great insights for UAV Propulsion Systems. Get free sample here: https://bisresearch.com/requestsample?id=1443&type=download
Fleet Management Market Trends, Key Players, Industry Analysis and Forecast 2...BIS Research Inc.
A fleet management system, which includes hardware, software and service, has the ability to make decisions for fleet managers and fleet businesses easily.
The ongoing research and development activities in this market are experiencing product launches of fleet management system for fleet owners, fleet managers, or businesses that utilize fleet management on a daily basis.
BIS Research has a new publication on Fleet Management, view free sample here : https://bisresearch.com/requestsample?id=1444&type=download
Agenda:
The main agenda of this webinar is to understand and explore the following:
• LoRaWAN adoption in agricultural applications as well as understanding the trends and key market developments.
• The significance of LoRaWAN in the field of IoT
• A comparative analysis between LoRaWAN and other IoT networks in terms of technology and capabilities.
• The impact of LoRaWAN on the operations of the agriculture industry and common use cases.
• The impact of the implementation of LoRaWAN technology on stakeholders in the agriculture ecosystem.
• The potential challenges that LoRaWAN might face in the future.
• The competitiveness of the market for LoRaWAN technology.
Augmented Reality in Agriculture Analysis and Statistics from 2022-2027BIS Research Inc.
AR depicts superimposing visual, audio, or other sensory data onto the physical world to improve one's experience. It is one of the most popular technological trends in today’s times. AR images can be displayed on a variety of devices, including eyeglasses and goggles, headsets, and heads-up displays such as helmet visors. As more smartphones, tablets, and other handheld devices that support AR are becoming available globally, the most popular way to use AR is on these devices in a variety of apps and games.
Although AR is used to visually communicate information, it is the integration of AR with other technologies that make it possible to adapt to precision farming and visual-based operations. Hence, farmers can utilize AR in combination with other technologies such as artificial intelligence (AI), big data, and the Internet of Things (IoT) to manage the rising food demand.
Get Augmented Reality in Agriculture report overview at: https://bisresearch.com/industry-report/ar-agriculture-market.html
Smart Harvest Market Generated Opportunities, Future Scope 2022-2027BIS Research Inc.
The growth in the global smart harvest market is expected to be driven by increasing smart farming practices among farmers, labor shortage, and growing government support for promoting the use of smart tech in the agriculture industry. Supported by government policies and technological developments, farmers and growers across the globe are expected to increase the implementation of smart harvest technologies. Moreover, the smart harvest market is witnessing several upcoming trends and opportunities, further propelling growth in the industry.
Get the PDF document on the technical aspects of Smart Harvest Market at: https://bisresearch.com/requestsample?id=1386&type=download
Precision Pest Management Market Leading Players, Development and Demand Fore...BIS Research Inc.
While farmers are losing crops due to pests, they have pressure to increase food production to feed the growing world population.
Precision pest management (PPM) is very important to avoid destruction caused by pests and to increase productivity. PPM helps to detect pests early with the help of crop monitoring so they can be controlled early to avoid further losses. The availability of advanced technologies and equipment has made agriculture automation more prevalent in developed countries.
To know more about the in-depth insights on precision pest management market, get PDF document: https://bisresearch.com/requestsample?id=1404&type=download
Agriculture Drones and Robots Market Growth Opportunity, Trends, Demand Analy...BIS Research Inc.
Agriculture drones and robots offer multiple benefits over conventional farming equipment, which is another factor driving the demand for these products in the agriculture industry. The adoption of agriculture drones and robots in commercial farms offers huge cost-saving opportunities.
Request for the Sample of the Report at: https://bisresearch.com/requestsample?id=1425&type=download
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...rowala30
Alka magic plan 1350 -we deliver alkaline water at your door step and you can make handsome money by referral programme
we also help and provide systematic guideline to setup 1000 lph alkaline water plant
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
1. Global Liquid
Biopsy Market
Focus on Market Segmentation by Product
Type, by Indication Type, by Technology, by
Biomarker, by Clinical Applications, by Sample
Type, by Usage, By Workflow, Geographical
and Competitive Landscape: Analysis and
Forecast: 2020-2030
September 2020
TOC
3. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 3
Table of Contents
Executive Summary……………………………………………...……………. 24
1. Product Definition ................................................................................................ 36
Inclusion and Exclusion ............................................................................. 36
2. Market Scope ........................................................................................................ 37
Scope of Work............................................................................................. 37
Key Questions Answered in the Report.................................................... 38
3. Research Methodology ........................................................................................ 39
Global Liquid Biopsy Market: Research Methodology ............................ 39
Data Sources ............................................................................................... 40
Secondary Data Sources............................................................................ 41
Market Estimation Model............................................................................ 41
Assumptions and Limitations ..................................................... 43
Data and Prediction Modeling ..................................................... 44
Criteria for Company Profiling................................................................... 44
4. Market Overview................................................................................................... 45
Market Size and Future Growth Potential ................................................. 45
Historical Trends......................................................................................... 46
Comparative Analysis of Tissue Biopsy and Liquid Biopsy ................... 47
Comparative Analysis of Liquid Biopsy Technologies............................ 48
5. Industry Insights................................................................................................... 50
Approval Scenario ...................................................................................... 50
Approved Liquid Biopsy by Major Players................................. 50
Launched Liquid Biopsies by Major Players ............................. 52
Regulatory Framework ............................................................................... 53
Regulatory Framework in the U.S ............................................... 53
5.2.1.1 Guidelines Recommendation .................................................... 53
5.2.1.2 Regulatory path for liquid biopsy diagnostic approvals ............. 54
Regulatory Framework in the European Union ......................... 54
4. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 4
Regulation in Other Countries .................................................... 55
Reimbursement Scenario........................................................................... 56
Case Study for Liquid Biopsy Reimbursement Analysis.......... 59
Patent Analysis ........................................................................................... 62
Key Players Patent Portfolio ....................................................... 62
Patent Filing Analysis .................................................................. 64
Key Players Patent Expiration Analysis..................................... 66
Financing Scenario ..................................................................................... 67
Key Players Stratification (as Per Raised Financing Value) ..... 67
Key Players Financing Analysis (FY2017-2019) ........................ 68
5.5.3 Investment Heat Map.................................................................... 70
Investors Heat Map....................................................................... 72
Supply Chain Analysis................................................................................ 72
Product Mapping Analysis ......................................................................... 74
By Technology.............................................................................. 74
By Sample Type............................................................................ 76
By Biomarker................................................................................ 79
By Application .............................................................................. 81
Physicians Perception................................................................................ 83
Investors Perception................................................................................... 84
Liquid Biopsy Government Initiatives....................................................... 85
Implication of COVID-19 Pandemic on Liquid Biopsy Market................. 87
6. Market Dynamics.................................................................................................. 92
Market Drivers ............................................................................................. 93
Rising Cancer Prevalence ........................................................... 93
Increasing Adoption of Inorganic Growth Strategies in the
Market............................................................................................ 94
Increase in Research Funding from National Cancer Institute 95
Market Restraints ........................................................................................ 98
False Negatives and Positives .................................................... 98
Uncertain Reimbursement and Regulatory Policies ................. 98
5. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 5
Expected Implementation of Patient Protection and Affordable
Care Act in the U.S ....................................................................... 99
Existing Diagnostic Confidence on Traditional Tissue-Based
Diagnosis Practices ................................................................... 100
Market Opportunities ................................................................................ 100
Potential Cost Savings............................................................... 100
Existing Applicability in Non-Availability of Tissue Sections for
Traditional Biopsy Approaches ................................................ 102
7. Competitive Insights .......................................................................................... 103
Key Strategies and Developments .......................................................... 103
Synergistic Activities ................................................................. 104
Regulatory Accreditations......................................................... 105
Product and Service Launches ................................................. 105
Acquisitions and Mergers.......................................................... 106
Approvals.................................................................................... 107
Market Share Analysis, 2019.................................................................... 108
Growth Share Analysis............................................................................. 110
Growth Share Analysis (by Prominent Companies)................ 110
Growth Share Analysis (by Technology).................................. 112
Growth Share Analysis (by Indication)..................................... 113
Growth Share Analysis (by Biomarker Type)........................... 114
Growth Share Analysis (by Clinical Application)..................... 115
8. Global Liquid Biopsy Market (by Product) ....................................................... 116
Tests/Services........................................................................................... 117
Kits and Consumables.............................................................................. 118
Instruments................................................................................................ 118
9. Global Liquid Biopsy Market (by Technology)................................................. 121
Overview .................................................................................................... 121
Next-Generation Sequencing................................................................... 122
Polymerase Chain Reaction..................................................................... 124
Digital PCR.................................................................................. 126
Multiplex PCR ............................................................................. 127
6. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 6
Real-Time PCR............................................................................ 128
Others.......................................................................................... 128
Fluorescence In-Situ Hybridization........................................... 129
Other Technologies .................................................................................. 131
10. Global Liquid Biopsy Market (by Workflow)..................................................... 132
Sample Preparation .................................................................................. 132
Library Preparation ................................................................................... 133
Sequencing................................................................................................ 135
Data Analysis and Management .............................................................. 137
11. Global Liquid Biopsy Market (by Usage).......................................................... 139
Overview .................................................................................................... 139
Clinical ....................................................................................................... 140
Research.................................................................................................... 140
12. Global Liquid Biopsy Marker (by Type of Sample) .......................................... 142
Overview .................................................................................................... 142
Blood.......................................................................................................... 143
Non-Blood Samples .................................................................................. 144
Urine ............................................................................................ 144
Saliva........................................................................................... 145
Cerebrospinal Fluid Samples .................................................... 147
13. Global Liquid Biopsy Market (by Circulating Biomarker) ............................... 148
Circulating Tumor Cells (CTCs)............................................................... 149
Cell-Free DNA (cfDNA).............................................................................. 151
Circulating Cell-Free RNAs ...................................................................... 152
Exosomes and Extracellular Vesicles and Others ................................. 153
Other Biomarkers...................................................................................... 154
14. Global Liquid Biopsy Market (by Indication).................................................... 156
Lung Cancer .............................................................................................. 157
Breast Cancer............................................................................................ 158
Prostate Cancer......................................................................................... 160
7. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 7
Colorectal Cancer ..................................................................................... 161
Melanoma................................................................................................... 162
Other Types of Cancer.............................................................................. 162
Non-Oncology Disorders.......................................................................... 163
15. Global Liquid Biopsy Market (by Clinical Application) ................................... 165
Treatment Monitoring ............................................................................... 166
Prognosis and Recurrence Monitoring ................................................... 166
Treatment Selection.................................................................................. 167
Diagnosis and Screening ......................................................................... 168
16. Global Liquid Biopsy Market (by Region)......................................................... 170
North America ........................................................................................... 171
U.S. .............................................................................................. 172
16.1.1.1 U.S. Liquid Biopsy Market (by Oncology Indication) ............... 175
Canada ........................................................................................ 176
16.1.2.1 Canada Liquid Biopsy Market (by Oncology Indication).......... 179
Europe........................................................................................................ 180
Germany...................................................................................... 182
16.2.1.1 Germany Liquid Biopsy Market (by Oncology Indication)........ 185
France.......................................................................................... 186
16.2.2.1 France Liquid Biopsy Market (by Oncology Indication) ........... 188
U.K. .............................................................................................. 190
16.2.3.1 U.K. Liquid Biopsy Market (by Oncology Indication) ............... 192
Italy .............................................................................................. 194
16.2.4.1 Italy Liquid Biopsy Market (by Oncology Indication)................ 196
Spain............................................................................................ 197
16.2.5.1 Spain Liquid Biopsy Market (by Oncology Indication) ............. 198
Rest-of-Europe ........................................................................... 200
Asia-Pacific................................................................................................ 201
China ........................................................................................... 203
16.3.1.1 China Liquid Biopsy Market (by Oncology Indication)............. 205
Japan........................................................................................... 206
8. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 8
16.3.2.1 Japan Liquid Biopsy Market (by Oncology Indication)............. 208
India............................................................................................................ 209
16.4.1.1 India Liquid Biopsy Market (by Oncology Indication)............... 211
Australia...................................................................................... 213
16.4.2.1 Australia Liquid Biopsy Market (by Oncology Indication) ........ 214
South Korea ................................................................................ 216
16.4.3.1 South Korea Liquid Biopsy Market (by Oncology Indication) .. 217
Singapore.................................................................................... 219
16.4.4.1 Singapore Liquid Biopsy Market (by Oncology Indication)...... 221
Rest-of-Asia-Pacific .................................................................................. 222
Latin America and Middle East ................................................................ 223
Brazil............................................................................................ 224
16.6.1.1 Brazil Liquid Biopsy Market (by Oncology Indication) ............. 226
Mexico ......................................................................................... 227
16.6.2.1 Mexico Liquid Biopsy Market (by Oncology Indication)........... 229
Saudi Arabia ............................................................................... 230
16.6.3.1 Saudi Arabia Liquid Biopsy Market (by Oncology Indication).. 232
Rest-of-Latin America and Middle East.................................... 234
Rest-of-the-World...................................................................................... 235
17. Company Profiles............................................................................................... 236
Overview .................................................................................................... 236
Abcodia Ltd. .............................................................................................. 237
Company Overview .................................................................... 237
Role of Abcodia Ltd. in the Liquid Biopsy Market................... 237
SWOT Analysis........................................................................... 239
Biocept, Inc................................................................................................ 240
Company Overview .................................................................... 240
Role of Biocept, Inc. in Liquid Biopsy Market.......................... 240
Financials.................................................................................... 241
Key Insights About Financial Health of the Company ............ 242
SWOT Analysis........................................................................... 243
Bio-Rad Laboratories, Inc......................................................................... 244
9. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 9
Company Overview .................................................................... 244
Role of Bio-Rad Laboratories, Inc. in Liquid Biopsy Market .. 244
Financials.................................................................................... 245
Key Insights About Financial Health of the Company ............ 248
SWOT Analysis........................................................................... 249
Cynvenio Biosystems, Inc........................................................................ 250
Company Overview .................................................................... 250
Role of Cynvenio Biosystems, Inc. in the Liquid Biopsy Market
..................................................................................................... 250
SWOT Analysis........................................................................... 252
Chronix Biomedical .................................................................................. 253
Company Overview .................................................................... 253
Role of Chronix Biomedical in the Liquid Biopsy Market....... 253
SWOT Analysis........................................................................... 254
Epic Sciences, Inc..................................................................................... 255
Company Overview .................................................................... 255
Role of Epic Sciences, Inc. in the Liquid Biopsy in the Market
..................................................................................................... 255
SWOT Analysis........................................................................... 257
F. Hoffmann-La Roche AG........................................................................ 258
Company Overview .................................................................... 258
Role of F. Hoffmann-La Roche AG in the Liquid Biopsy
Market.......................................................................................... 258
Financials.................................................................................... 259
Key Insights About Financial Health of the Company ............ 261
SWOT Analysis........................................................................... 262
GUARDANT HEALTH, INC........................................................................ 263
Company Overview .................................................................... 263
Role of GUARDANT HEALTH, Inc. in Liquid Biopsy Market... 263
Financials.................................................................................... 265
Key Insights About Financial Health of the Company ............ 267
SWOT Analysis........................................................................... 268
Illumina, Inc. .............................................................................................. 269
10. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 10
Company Overview .................................................................... 269
Role of Illumina, Inc. in the Liquid Biopsy Market................... 269
Financials.................................................................................... 271
Key Insights About Financial Health of the Company ............ 273
SWOT Analysis........................................................................... 274
Menarini Silicon Biosystems, Inc. ........................................................... 275
Company Overview .................................................................... 275
Role of Menarini Silicon Biosystems in the Liquid Biopsy
Market.......................................................................................... 275
SWOT Analysis........................................................................... 277
NeoGenomics Laboratories, Inc. ............................................................. 278
Company Overview .................................................................... 278
Role of NeoGenomics Laboratories, Inc. in the Liquid Biopsy
Market.......................................................................................... 278
Financials.................................................................................... 280
Key Insights About Financial Health of the Company ............ 281
SWOT Analysis........................................................................... 282
Personal Genome Diagnostics, Inc. ........................................................ 283
Company Overview .................................................................... 283
Role of Personal Genome Diagnostics in the Liquid Biopsy
Market.......................................................................................... 283
SWOT Analysis........................................................................... 285
Qiagen N.V................................................................................................. 286
Company Overview .................................................................... 286
Role of Qiagen N.V. in the Liquid Biopsy Market .................... 286
Financials.................................................................................... 287
Key Insights about Financial Health of the Company............. 289
SWOT Analysis........................................................................... 290
Resolution Bioscience, Inc....................................................................... 291
Company Overview .................................................................... 291
Role of Resolution Biosciences, Inc. in the Liquid Biopsy
Market.......................................................................................... 291
SWOT Analysis........................................................................... 293
11. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 11
Thermo Fisher Scientific .......................................................................... 294
Company Overview .................................................................... 294
Role of Thermo Fisher Scientific in the Liquid Biopsy
Market.......................................................................................... 294
Financials.................................................................................... 296
Key Insights About Financial Health of the Company ............ 298
SWOT Analysis........................................................................... 299
12. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 12
List of Tables
Table 1: Most Common Cancers
Table 2: Existing Patients Issues with Standard Tissue Biopsies and Surgical Procedures
Table 4.1: Global Liquid Biopsy Market, by Region, ($Million), 2019-2030
Table 4.2: Comparative Analysis of Liquid Biopsy vs. Tissue Biopsy
Table 4.3: Comparative Analysis of Liquid Biopsy Technologies
Table 5.1: Approved Liquid Biopsy Test Kits from Major Players
Table 5.2: List of Other Non-EGFR Liquid Biopsies Kits
Table 5.3: List of Major Players Liquid Biopsies
Table 5.4: Elements for the Liquid Biopsy Regulatory Submission
Table 5.5: Reimbursement Scenario for Key Players Offerings in Global Liquid Biopsy Market
Table 5.6: Reimbursement Landscaping for Liquid Biopsies (FY2015-FY2019)
Table 5.7: Global Liquid Biopsy Market (Key Players Patent Portfolio)
Table 5.8: Investment Heat Map
Table 5.9: Investors Heat Map
Table 5.10: Liquid Biopsy Product Mapping Analysis (by Technology Type)
Table 5.11: Liquid Biopsy Product Mapping Analysis (by Sample Type)
Table 5.12: Liquid Biopsy Product Mapping Analysis by Biomarker
Table 5.13: Liquid Biopsy Product Mapping Analysis by Application
Table 5.14: Government Initiatives for Liquid Biopsies
Table 6.1: Pricing List of Key Players Liquid Biopsies
Table 13.1: Comparison between the applications of ctDNA, CTCs, and exosomes
Table 16.1: Type-Specific Prevalence of Cancers in the U.S
Table 16.2: Type-specific Prevalence of Cancers in Canada
Table 16.3: Type-Specific Prevalence of Cancers in Germany
Table 16.4: Type-Specific Prevalence of Cancers in France
Table 16.5: Type-Specific Prevalence of Cancers in the U.K
Table 16.6: Type-specific Prevalence of Cancers in Italy
Table 16.7: Type-Specific Prevalence of Cancers in Spain
Table 16.8: Type-Specific Prevalence of Cancers in China
Table 16.9: Type-Specific Prevalence of Cancers in Japan
Table 16.10: Type-Specific Prevalence of Cancers in India
Table 16.11: Type-Specific Prevalence of Cancers in Australia
Table 16.12: Type-Specific Prevalence of Cancers in South Korea
Table 16.13: Type-Specific Prevalence of Cancers in Singapore
Table 16.14: Type-Specific Prevalence of Cancers in Brazil
13. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 13
Table 16.15: Type-specific Prevalence of Cancers in Mexico
Table 16.16: Type-Specific Prevalence of Cancers in Saudi Arabia
14. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 14
List of Figures
Figure 1: Type of Cancer Diagnostics
Figure 2: Considerations for Liquid Biopsy
Figure 3: Impact Analysis of Market Drivers and Market Challenges on the Global Liquid Biopsy
Market
Figure 4: Global Liquid Biopsy Market (by Technology), $Million, 2020 and 2030
Figure 5: Global Liquid Biopsy Market (by Workflow), $Million, 2020 and 2030
Figure 6: Global Liquid Biopsy Market (by Usage), $Million, 2020 and 2030
Figure 7: Global Liquid Biopsy Market (by Type of Sample), $Million, 2020 and 2030
Figure 8: Global Liquid Biopsy Market (by Circulating Biomarkers), $Million, 2020 and 2030
Figure 9: Global Liquid Biopsy Market (by Products), $Million, 2020 and 2030
Figure 10: Global Liquid Biopsy Market (by Indication), $Million, 2020 and 2030
Figure 11: Global Liquid Biopsy Market (by Clinical Application), $Million, 2020 and 2030
Figure 12: Global Liquid Biopsy Market (by Region), $Million, 2019
Figure 2.1: Global Liquid Biopsy Market Segmentation
Figure 3.1: Global Liquid Biopsy Market Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Global Liquid Biopsy Market, 2019-2030 ($Million)
Figure 4.2: Historical Evolution of Liquid Biopsy Testing
Figure 5.1: Key Findings from Liquid Biopsy Reimbursement Study
Figure 5.2: Liquid Biopsy Market, Percent Split of Filed Patients (FY2014-FY2018)
Figure 5.3: Liquid Biopsy Patent Analysis (FY2014-FY2018)
Figure 5.4: Patent Expiration Analysis
Figure 5.5: Key Players Financing Stratification
Figure 5.6: Financing Analysis (FY2017-FY2019), US$ Million
Figure 5.7: Liquid Biopsies Key Players Financing Analysis
Figure 5.8: Liquid Biopsy Supply Chain Analysis
Figure 5.9: Physicians Perceptions for Liquid Biopsies
Figure 5.10: Investors Perception
Figure 5.11: Recent Government Initiatives to Debunk the Negative Impact of COVID-19 on Liquid
Biopsy Industry
Figure 5.12: Impact of COVID-19 on Liquid Biopsy Testing Industry
Figure 5.13: Implication of COVID-19 on Liquid Biopsy Testing Landscape
Figure 5.14: Key Liquid Biopsy Testing Players
15. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 15
Figure 5.15: Challenges Faced by Liquid Biopsy Key Players due to COVID-19
Figure 5.16: Steps to Mitigate the Impact on COVID-19 on Liquid Biopsy Testing Industry
Figure 6.1: Market Dynamics of Global Liquid Biopsy Market
Figure 6.2: Cancer Prevalence Trends**, (2013-2017)
Figure 6.3: Synergistic Activities, 2018-2019
Figure 6.4: SBIR and STTR Grants and Contract Funding 2008-2018
Figure 6.5: NCI Fiscal Budget Year on Year, 2013-2018
Figure 6.6: Case Scenario: NSCLC Liquid Biopsy Coverage Status of Payors
Figure 7.1: Share of Key Developments and Strategies, January 2017-January 2019
Figure 7.2: Synergistic Activities Share (by Company), January 2017-December 2019
Figure 7.3: Accreditations Share (by Company), January 2017-December 2019
Figure 7.4: Product and Service Launches Share (by Company), January 2017- December 2019
Figure 7.5: Mergers and Acquisitions (by Company), January 2017-December 2019
Figure 7.6: Regulatory Approvals (by Company), January 2017-December 2019
Figure 7.7: Global Liquid Biopsy Market Share Analysis 2018 Vs 2019
Figure 7.8: Growth Share Matrix for Global Liquid Biopsy Market (by Company), 2019
Figure 7.9: Growth Share Matrix for Global Liquid Biopsy Market (by Technology), 2019
Figure 7.10: Growth Share Analysis (by Indication), 2019
Figure 7.11: Growth Share Analysis (by Biomarker Type), 2019
Figure 7.12: Growth Share Analysis (by Clinical Application), 2019
Figure 8.1: Global Liquid Biopsy Market (by Product), 2020 vs. 2030
Figure 8.2: Global Liquid Biopsy Market (by Test/Service), 2019-2030
Figure 8.3: Global Liquid Biopsy Market (by Kits and Consumables), 2019-2030
Figure 8.4: Global Liquid Biopsy Market (by Instruments), 2019-2030
Figure 9.1: Global Liquid Biopsy Market (by Technology), 2020 vs. 2030
Figure 9.2: Global Liquid Biopsy Market (by Next Generation Sequencing), 2019-2030
Figure 9.3: Global Liquid Biopsy Market (by Polymerase Chain Reaction), 2019-2030
Figure 9.4: Global Liquid Biopsy Market (by Digital PCR Technology), 2019-2030
Figure 9.5: Global Liquid Biopsy Market (by Multiplex PCR Technology), 2019-2030
Figure 9.6: Global Liquid Biopsy Market (by Real-Time PCR Technology), 2019-2030
Figure 9.7: Global Liquid Biopsy Market (by Other PCR Technologies), 2019-2030
Figure 9.8: Global Liquid Biopsy Market (by FISH), 2019-2030
Figure 9.9: Global Liquid Biopsy Market (by Other Technologies), 2019-2030
Figure 10.1: Global Liquid Biopsy Market (by Workflow), 2020 Vs. 2030
Figure 10.2: Global Liquid Biopsy Market (by Sample Preparation Segment), 2019-2030
Figure 10.3: Global Liquid Biopsy Market (by Library Preparation Segment), 2019-2030
Figure 10.4: Global Liquid Biopsy Market (by Sequencing Segment), 2019-2030
Figure 10.5: Global Liquid Biopsy Market (by Data Analysis and Management Segment), 2019-2030
16. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 16
Figure 11.1: Global Liquid Biopsy Market (by Usage), 2020 vs. 2030
Figure 11.2: Global Liquid Biopsy Market (by Clinical Applications), 2019-2030
Figure 11.3: Global Liquid Biopsy Market (by Research Applications), 2019-2030
Figure 12.1: Global Liquid Biopsy Market (by Type of Sample), 2020 vs. 2030
Figure 12.2: Global Liquid Biopsy Market (by Blood Sample), 2019-2030
Figure 12.3: Global Liquid Biopsy Market (by Urine), 2019-2030
Figure 12.4: Global Liquid Biopsy Market (by Saliva), 2019-2030
Figure 12.5: Global Liquid Biopsy Market (by Cerebrospinal Fluid), 2019-2030
Figure 13.1: Global Liquid Biopsy Market (by Circulating Biomarkers), 2020 vs. 2030
Figure 13.2: Global Liquid Biopsy Market (by Circulating Tumor Cells), 2019-2030
Figure 13.3: Global Liquid Biopsy Market (by Cell-Free DNA), 2019-2030
Figure 13.4: Global Liquid Biopsy Market (by Circulating Cell-Free RNA), 2019-2030
Figure 13.5: Global Liquid Biopsy Market (by Exosomes and Extracellular Vesicles), 2019-2030
Figure 13.6: Global Liquid Biopsy Market (by Other Biomarkers), 2019-2030
Figure 14.1: Global Liquid Biopsy Market (by Indication)
Figure 14.2: Global Liquid Biopsy Market (by Indication), 2020 vs. 2030
Figure 14.3: Global Liquid Biopsy Market (by Lung Cancer), 2019-2030
Figure 14.4: Global Liquid Biopsy Market (by Breast Cancer), 2019-2030
Figure 14.5: Global Liquid Biopsy Market (by Prostate Cancer), 2019-2030
Figure 14.6: Global Liquid Biopsy Market (by Colorectal Cancer), 2019-2030
Figure 14.7: Global Liquid Biopsy Market (by Melanoma), 2019-2030
Figure 14.8: Global Liquid Biopsy Market (by Other Type of Cancers), 2019-2030
Figure 14.9: Global Liquid Biopsy Market (by Non-Oncology Disorders), 2019-2030
Figure 15.1: Global Liquid Biopsy Market (by Clinical Application), 2020 vs. 2030
Figure 15.2: Global Liquid Biopsy Market (by Treatment Monitoring), 2019-2030
Figure 15.3: Global Liquid Biopsy Market (by Prognosis and Recurrence Monitoring), 2019-2030
Figure 15.4: Global Liquid Biopsy Market (by Treatment Selection), 2019-2030
Figure 15.5: Global Liquid Biopsy Market (by Diagnosis and Screening), 2019-2030
Figure 16.1: Global Liquid Biopsy Market (by Region), 2020 vs. 2030
Figure 16.2: Global Liquid Biopsy Market (by North America), 2020-2030
Figure 16.3: Market Dynamics of North American Liquid Biopsy Market
Figure 16.4: U.S. Liquid Biopsy Market, 2019-2030
Figure 16.5: Cancer Prevalence Trends in the U.S (2013-2017)
Figure 16.6: U.S Liquid Biopsy Market (by Oncology Indications), 2019-2030
Figure 16.7: U.S Liquid Biopsy Market (by Type of Cancer)
Figure 16.8: Canada Liquid Biopsy Market, 2019-2030
Figure 16.9: Cancer Prevalence Trends in Canada (2013-2017)
Figure 16.10: Canada Liquid Biopsy Market (by Oncology Indications), 2019-2030
17. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 17
Figure 16.11: Canada Liquid Biopsy Market (by Types of Cancers)
Figure 16.12: Global Liquid Biopsy Market (by Europe), 2020 vs. 2030
Figure 16.13: Market Dynamics of European Liquid Biopsy Market
Figure 16.14: Germany Liquid Biopsy Market, 2019-2030
Figure 16.15: Cancer Prevalence Trends in Germany (2013-2017)
Figure 16.16: Germany Liquid Biopsy Market (by Oncology Indication), 2019-2030
Figure 16.17: Germany Liquid Biopsy Market by Type of Cancers
Figure 16.18: France Liquid Biopsy Market, 2019-2030
Figure 16.19: Cancer Prevalence Trends in France (2013-2017)
Figure 16.20: France Liquid Biopsy Market (by Oncology Indications), 2019-2030
Figure 16.21: France Liquid Biopsy Market by Type of Cancers
Figure 16.22: U.K. Liquid Biopsy Market, 2019-2030
Figure 16.23: Cancer Prevalence Trends in the U.K. (2013-2017)
Figure 16.24: The U.K Liquid Biopsy Market, (by Oncology Indications), 2019-2030
Figure 16.25: U.K. Liquid Biopsy Market by Type of Cancers
Figure 16.26: Italy Liquid Biopsy Market, 2019-2030
Figure 16.27: Cancer Prevalence Trends in Italy (2013-2017)
Figure 16.28: Italy Liquid Biopsy Market, (by Oncology Indications), 2019-2030
Figure 16.29: Italy Liquid Biopsy Market by Type of Cancers
Figure 16.30: Spain Liquid Biopsy Market, 2019-2030
Figure 16.31: Cancer Prevalence Trends in Spain (2013-2017)
Figure 16.32: Spain Liquid Biopsy Market, (by Oncology Indications), 2019-2030
Figure 16.33: Spain Liquid Biopsy Market by Type of Cancers
Figure 16.34: Rest-of-Europe Liquid Biopsy Market, 2019-2030
Figure 16.35: Asia-Pacific Liquid Biopsy Market, 2020 vs. 2030
Figure 16.36: Market Dynamics of Asia-Pacific Liquid Biopsy Market
Figure 16.37: China Liquid Biopsy Market, 2019-2030
Figure 16.38: Cancer Prevalence Trends in China (2013-2017)
Figure 16.39: China Liquid Biopsy Market (by Oncology Indication), 2019-2030
Figure 16.40: China Liquid Biopsy Market by Types of Cancer
Figure 16.41: Japan Liquid Biopsy Market, 2019-2030
Figure 16.42: Cancer Prevalence Trends in Japan (2013-2017)
Figure 16.43: Japan Liquid Biopsy Market (by Oncology Indications), 2019-2030
Figure 16.44: Japan Liquid Biopsy Market by Types of Cancer
Figure 16.45 India Liquid Biopsy Market, 2019-2030
Figure 16.46: Cancer Prevalence Trends in India (2013-2017)
Figure 16.47: India Liquid Biopsy Market (by Oncology Indications), 2019-2030
Figure 16.48: India Liquid Biopsy Market by Type of Cancers
18. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 18
Figure 16.49: Australia Liquid Biopsy Market, 2019-2030
Figure 16.50: Cancer Prevalence Trends in Australia (2013-2017)
Figure 16.51: Australia Liquid Biopsy Market, (by Oncology Indications), 2019-2030
Figure 16.52: Australia Liquid Biopsy Market by Types of Cancer
Figure 16.53: South Korea Liquid Biopsy Market, 2019-2030
Figure 16.54: Cancer Prevalence Trends in South Korea (2013-2017)
Figure 16.55: South Korea Liquid Biopsy Market, (by Oncology Indications), 2019-2030
Figure 16.56: South Korea Liquid Biopsy Market by Types of Cancer
Figure 16.57: Singapore Liquid Biopsy Market, 2019-2030
Figure 16.58: Cancer Prevalence Trends in Singapore (2013-2017)
Figure 16.59: Singapore Liquid Biopsy Market, (by Oncology Indication), 2019-2030
Figure 16.60: Singapore Liquid Biopsy Market by Type of Cancers
Figure 16.61: Rest-of-Asia-Pacific Liquid Biopsy Market, 2019-2030
Figure 16.62: Latin-America and Middle East Liquid Biopsy Market, 2020 vs. 2030
Figure 16.63: Market Dynamics of Latin America and Middle Eastern Liquid Biopsy Market
Figure 16.64: Brazil Liquid Biopsy Market, 2019-2030
Figure 16.65: Cancer Prevalence Trends in Brazil (2013-2017)
Figure 16.66: Brazil Liquid Biopsy Market (by Oncology Indication), 2019-2030
Figure 16.67: Brazil Liquid Biopsy Market by Type of Cancers
Figure 16.68: Mexico Liquid Biopsy Market, 2019-2030
Figure 16.69: Cancer Prevalence Trends in Mexico (2013-2017)
Figure 16.70: Mexico Liquid Biopsy Market (by Oncology Indications), 2019-2030
Figure 16.71: Mexico Liquid Biopsy Market by Types of Cancer
Figure 16.72: Saudi Arabia Liquid Biopsy Market, 2019-2030
Figure 16.73: Cancer Prevalence Trends in Saudi Arabia (2013-2017)
Figure 16.74: Saudi Arabia Liquid Biopsy Market (by Oncology Indication), 2019-2030
Figure 16.75: Saudi Arabia Liquid Biopsy Market by Types of Cancer
Figure 16.76: Rest-of-Latin America and Middle East Liquid Biopsy Market, 2019-2030
Figure 16.77: Rest-of-the-World Liquid Biopsy Market, 2019-2030
Figure 17.1: Total Number of Companies Profiled
Figure 17.2: Abcodia Product Portfolio
Figure 17.3: SWOT Analysis: Abcodia Ltd.
Figure 17.4: Biocept, Inc.: Portfolio
Figure 17.5: Biocept Inc.: Overall Financials, 2017-2019
Figure 17.6: Biocept, Inc.: R&D Expenditure, 2017-2019
Figure 17.7: SWOT Analysis: Biocept Inc
Figure 17.8: Bio-Rad Laboratories, Inc.: Portfolio
Figure 17.9: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
21. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 21
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in
today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates
and institutions worldwide and assist them with market intelligence in the area of emerging
technologies, advisories, and other innovative solutions.
Know More Know More
Know More
Know More
22. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 22
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in
response to orders. The report is licensed for the customer's internal use only and is subject to
restrictions set henceforth. This document and its contents are confidential and may not be further
distributed, published or reproduced, in whole or in part, by any medium or in any form for any
purpose, without the written consent of BIS Research. The customer will not disclose the contents of
the report, whether directly through any medium or indirectly through incorporation in a database,
marketing list, report or otherwise, or use or permit the use of information to generate any statistical
or other information that is or will be provided to third parties, or voluntarily produce information in
legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such information
is available. Any recommendation contained in this report may not be suitable for all investors or
businesses. The market conclusions drawn are necessarily based upon a number of estimates and
assumptions that, while considered reasonable by BIS Research as of the date of such statements,
are inherently subject to market fluctuations and business, economic and competitive uncertainties
and contingencies
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135
23. Global Liquid Biopsy Market-2020
All rights reserved at BIS Research 23
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: info@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544